BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3912573)

  • 1. [The sensitivity and specificity of tumor markers (CEA, ferritin, beta 2-MG, TPA, IAP, sialic acid) in malignant and non-malignant pulmonary diseases and their relation to smoking and sex].
    Reshad K; Suzuki K; Inui K; Takahashi Y; Umemiya M; Nakano Y; Sakamoto M; Takeuchi Y; Shimada T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1343-50. PubMed ID: 3912573
    [No Abstract]   [Full Text] [Related]  

  • 2. [Auxiliary value of TPA in diagnosing neoplastic diseases].
    Mizushima Y; Nakamura F; Yokoyama A; Morikage T; Kawasaki S; Hoshino K; Maruyama M; Yamashita N; Yano S
    Gan No Rinsho; 1986 Jun; 32(7):779-82. PubMed ID: 3735675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of serum tumor markers (CEA, TPA, IAP and ferritin) in pulmonary tuberculosis].
    Komatsu H
    Kekkaku; 1987 Jan; 62(1):31-6. PubMed ID: 3573509
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of tumor markers in breast cancer patients].
    Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor-associated markers in malignant lung neoplasms].
    Piancino G; Racca P; Rayneri W; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1986 Jan; 77(1-2):19-25. PubMed ID: 3945411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical study on CEA, TPA, ADA, ferritin, beta 2 microglobulin and sialic acid levels in pleural effusion].
    Reshad K; Suzuki K; Itoi K; Takahashi Y; Hirata T; Yagi T; Sato A; Nakano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Nov; 25(11):1174-80. PubMed ID: 3329690
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
    Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of CEA levels in lung cancer].
    Noge S; Hara N; Ichinose Y; Ishimatsu T; Motohiro A; Etoh K; Miyake J; Ohta M
    Gan No Rinsho; 1985 May; 31(6 Suppl):616-22. PubMed ID: 2993691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta 2 microglobulin and CEA in the blood and homogenate: comparison in neoplastic and non-neoplastic pulmonary pathology].
    Abbasciano V; Felisatti G; Arcadi A; Abbasciano N; Ferroci V; Pittini S
    Riv Emoter Immunoematol; 1983; 30(3):271-81. PubMed ID: 6366997
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis of tumors with the use of immunologic tumor markers].
    Vorlaender KO
    Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer.
    Gail MH; Muenz L; McIntire KR; Radovich B; Braunstein G; Brown PR; Deftos L; Dnistrian A; Dunsmore M; Elashoff R
    J Natl Cancer Inst; 1986 May; 76(5):805-16. PubMed ID: 2422426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
    Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ferritin, CEA and TPA as tumor markers in breast neoplasms].
    Bonanni F; Folco U; Giudici Cipriani A; Buffa E; Amedeo A; Bertolotto M; Rembado R; Barbetti V; Guglieri F
    Minerva Med; 1985 Sep; 76(34-35):1533-4. PubMed ID: 4034052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Kamamoto Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1496-504. PubMed ID: 6520506
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic predictability of CEA and TPA tumor markers in bronchoalveolar lavage fluid].
    Loos U; Oehr P; Genske F; Schlack W
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():235-7. PubMed ID: 3174571
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of six tumor markers (ferritin, CEA, TPA, AFP, PAP, gamma-Sm) in serum in patients with urogenital malignancies].
    Koizumi F; Nakamura E; Kawamura T; Ishimori A; Hoshi S; Matsuda S
    Rinsho Byori; 1986 Sep; 34(9):1053-8. PubMed ID: 2432295
    [No Abstract]   [Full Text] [Related]  

  • 18. [Distribution and prognostic value of CEA and TPA in cancer of the lung].
    Leonardo E; Dogliotti C; Mancuso M; Sanfilippo B; Oliaro A
    Minerva Med; 1986 Mar; 77(11):375-9. PubMed ID: 3703330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
    Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
    Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
    Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
    Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.